Order results by:
| Issue | Title | |
| Vol 17, No 2 (2024) | The effectiveness of rehabilitation in vulvovaginal atrophy | Abstract similar documents |
| D. М. Ampilogova, А. G. Solopova, D. V. Blinov, А. Е. Ivanov, S. V. Khlopkova, G. К. Bykovshchenko | ||
| "... ) and natural (n=140) menopause, the control group included 70 women without VVA. Patients with VVA were ..." | ||
| Vol 15, No 2 (2022) | Strengthening medical rehabilitation services in health system: a situation analysis | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, L. N. Sandzhieva, E. E. Achkasov, D. I. Korabelnikov, D. M. Ampilogova, S. M. Khlopkova | ||
| "... rehabilitation (MR) in the Russian Federation. Material and methods. We analyzed the valid Order of the Ministry ..." | ||
| Vol 17, No 2 (2024) | Mathematical modeling and analysis of export trends for certain pharmaceutical groups | Abstract similar documents |
| А. R. Shaikhislamova, N. А. Gasratova | ||
| "... Background. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 ..." | ||
| Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
| "... treatment in studied regions are covered by the average tariff for the corresponding diagnosis-related group ..." | ||
| Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
| "... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..." | ||
| Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
| D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
| "... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..." | ||
| Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
| M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
| "... The existing model of financial support of medical assistance for clinical-statistical groups (CSGs ..." | ||
| Vol 7, No 3 (2014) | PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY | Abstract similar documents |
| V. S. Dombrovskiy, V. V. Omelyanovskiy | ||
| "... on the disability group changes is not sensitive enough for the evaluation of rehabilitation programs efficacy ..." | ||
| Vol 10, No 4 (2017) | THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE | Abstract similar documents |
| Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva | ||
| "... and statistical groups. ..." | ||
| Vol 11, No 2 (2018) | Introduction of medical products into healthcare practice and costs reimbursement: European experience | Abstract similar documents |
| V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii | ||
| Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
| I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
| "... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..." | ||
| Vol 17, No 4 (2024) | Proteomic analysis of synergetic neuroprotective effect of adenosine, thiamine, niacin and cyanocobalamin in pathophysiology of diabetic polyneuropathy | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Moiseenok | ||
| "... Background. Neurotransmitter adenosine and B-group vitamins have neuroprotective, remyelinizing ..." | ||
| Vol 15, No 4 (2022) | Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction | Abstract similar documents |
| D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko | ||
| "... rehabilitation programs designed to improve the quality of life (QoL) in this category of gynecological patients ..." | ||
| Vol 17, No 2 (2024) | Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access | Abstract similar documents |
| I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy | ||
| "... of diagnosis-related groups (DRGs) for cases of surgical medical care provided by laparoscopic access ..." | ||
| Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
| A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
| "... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..." | ||
| Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract similar documents |
| E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
| "... Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV ..." | ||
| Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
| E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
| "... Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage ..." | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| "... -related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been ..." | ||
| Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract similar documents |
| Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
| Online First | Clinical and economic assessment of nosocomial pneumonia antibacterial therapy in Moscow hospital | Abstract similar documents |
| D. D. Ivanova, I. N. Sychev, N. B. Lazareva | ||
| "... ABDs included 31 international nonproprietary names of the group J01 Systemic antibacterial drugs ..." | ||
| Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
| I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
| "... групп населения федерального и регионального уровней ответственности. На основании полученных значений ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| A. U. Kulikov, I. A. Komarov | ||
| "... of this group of patients. We performed budget impact analysis on the basis of two bronchodilators in Russian ..." | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| "... of randomized controlled trials (RCT) and indirect RCT comparison. The expenditures for drugs of TRA group ..." | ||
| Vol 15, No 2 (2022) | Epigenetic aspects in rehabilitation of female cancer patients | Abstract similar documents |
| A. G. Solopova, D. V. Blinov, S. V. Demyanov, G. V. Demyanov, E. E. Achkasov, A. Yu. Vlasina, L. N. Sandzhieva, D. M. Ampilogova | ||
| "... and relapse. However, “epigenetic markers” of carcinogenesis can be useful in the treatment and rehabilitation ..." | ||
| Vol 6, No 2 (2013) | COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| "... of this pathology contributes to the improvement of approaches to treatment policy of this group of patients. We ..." | ||
| Vol 6, No 3 (2013) | COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract similar documents |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| "... contributes to the improvement of approaches to treatment policy of this group of patients. We performed cost ..." | ||
| Vol 16, No 2 (2023) | Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko | ||
| "... to organize rehabilitation measures that significantly increase the quality of life of oncogynecological ..." | ||
| Vol 15, No 1 (2022) | Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, A. N. Plutnitskiy, D. M. Ampilogova, L. N. Sandzhieva, D. I. Korabel’nikov, D. A. Petrenko | ||
| "... relationship, which leads to a limitation of physiological and social possibilities. Rehabilitation programs ..." | ||
| Vol 7, No 1 (2014) | PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY | Abstract similar documents |
| D. V. Blinov | ||
| "... and rehabilitation for patients with neurological disorders. Objective: to evaluate the dynamics of serum ..." | ||
| Vol 11, No 4 (2018) | “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment | Abstract similar documents |
| I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova | ||
| "... to develop a plan of further actions for each specific group. This contributes to the development ..." | ||
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract similar documents |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| Vol 15, No 1 (2022) | Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova | ||
| "... . Preparation for endoprosthetics and rehabilitation after surgery usually includes measures to improve ..." | ||
| Vol 9, No 1 (2016) | REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES | Abstract similar documents |
| K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... is based on per case of treatment for a relevant group of diseases (diagnosis related group (DRG ..." | ||
| Vol 5, No 3 (2012) | COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES | Abstract similar documents |
| M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova | ||
| "... of two group. Patients of the first (main) group received a course of intraosseous blockades, while ..." | ||
| Vol 8, No 2 (2015) | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA | Abstract similar documents |
| Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova | ||
| "... divided into 4 groups depending on their therapy. The period of observation was 12 months. The 1st group ..." | ||
| Vol 12, No 2 (2019) | New framework for the development of clinical guidelines in Russia | Abstract similar documents |
| D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov | ||
| "... information on the disease, diagnosis, treatment, medical rehabilitation, prevention and follow-up care ..." | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| "... patient-reported SMA registry, insurance medical companies, epidemiological, and rehabilitation care data ..." | ||
| Vol 11, No 2 (2018) | Clinical and economic efficiency of the loop ileostomy closure by various methods | Abstract similar documents |
| A. V. Veselov, S. I. Achkasov, O. I. Sushkov, A. I. Moskalev, I. S. Lantsov | ||
| "... and methods. The study included 327 patients randomized into 3 groups. in group 1, the closure of an ileostomy ..." | ||
| Vol 15, No 1 (2022) | Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution | Abstract similar documents |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov | ||
| "... by the change in costs for various pharmacotherapeutic groups of medications in two segments (domestic ..." | ||
| Vol 5, No 2 (2012) | WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM | Abstract similar documents |
| A. I. Borodin | ||
| "... necessity of working out the scientifically-proved strategy of storekeeping by different groups of medicines ..." | ||
| Vol 7, No 4 (2014) | MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES | Abstract similar documents |
| M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya | ||
| "... with subsequent transfer him to the medical rehabilitation. Under the conditions of this model the expected cost ..." | ||
| Vol 13, No 2 (2020) | Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation | Abstract similar documents |
| S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| "... of therapy for bleeding complications (in the structure of the costs, it occupied 30-38%). In the group ..." | ||
| Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
| D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
| "... patients were divided into two groups: the main group – 34 women administered with vitamin D, comparison ..." | ||
| Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
| "... Objective: to study the features of the population consumption of antitumor drugs (ATDs) of groups ..." | ||
| Vol 16, No 4 (2023) | Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis | Abstract similar documents |
| A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva | ||
| "... in an observational, open, prospective study. In the main group (n=85), a combined therapy consisting of standard CT ..." | ||
| Vol 7, No 1 (2014) | CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT | Abstract similar documents |
| I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov | ||
| "... groups according to the therapy (imipenem, meropenem, doripenem). There were no statistically significant ..." | ||
| Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
| Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
| "... (6% in the Levilimab group and 10% in the standard therapy group; odds ratio (OR) 1.71; 95 ..." | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| "... . The groups of drugs widely used in clinical practice are disease-modifying osteoarthritis drugs (DMOADs ..." | ||
| Vol 18, No 1 (2025) | Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients | Abstract similar documents |
| M. E. Mantsaeva, D. I. Korabelnikov, A. G. Borisov | ||
| "... were divided into two groups depending on the presence of anti-DGP IgA: the main group (n=20 ..." | ||
| Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract similar documents |
| I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
| "... are systematized according to inclusion / exclusion criteria. All patients were divided into 3 groups: group 1 (n ..." | ||
| 1 - 50 of 174 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
